These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31857571)

  • 41. Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    Franz F; Angerer V; Moosmann B; Auwärter V
    Drug Test Anal; 2017 May; 9(5):744-753. PubMed ID: 27504870
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.
    Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA
    Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synthetic cannabinoid 3-benzyl-5-[1-(2-pyrrolidin-1-ylethyl)-1H-indol-3-yl]-1,2,4-oxadiazole. The first detection in illicit market of new psychoactive substances.
    Shevyrin V; Melkozerov V; Eltsov O; Shafran Y; Morzherin Y
    Forensic Sci Int; 2016 Feb; 259():95-100. PubMed ID: 26771874
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Metabolism of Nine Synthetic Cannabinoid Receptor Agonists Encountered in Clinical Casework: Major in vivo Phase I Metabolites of AM-694, AM-2201, JWH-007, JWH-019, JWH-203, JWH-307, MAM-2201, UR-144 and XLR-11 in Human Urine Using LC-MS/MS.
    Hutter M; Broecker S; Kneisel S; Franz F; Brandt SD; Auwarter V
    Curr Pharm Biotechnol; 2018; 19(2):144-162. PubMed ID: 29745330
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prevalence and Risk Factors of Stress Cardiomyopathy After Convulsive Status Epilepticus in ICU Patients.
    Belcour D; Jabot J; Grard B; Roussiaux A; Ferdynus C; Vandroux D; Vignon P
    Crit Care Med; 2015 Oct; 43(10):2164-70. PubMed ID: 26237133
    [TBL] [Abstract][Full Text] [Related]  

  • 46. 1-Adamantylamine a simple urine marker for screening for third generation adamantyl-type synthetic cannabinoids by ultra-performance liquid chromatography tandem mass spectrometry.
    Ford LT; Berg JD
    Ann Clin Biochem; 2016 Nov; 53(6):640-646. PubMed ID: 26748105
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthetic cannabinoids JWH-018, JWH-122, UR-144 and the phytocannabinoid THC activate apoptosis in placental cells.
    Almada M; Alves P; Fonseca BM; Carvalho F; Queirós CR; Gaspar H; Amaral C; Teixeira NA; Correia-da-Silva G
    Toxicol Lett; 2020 Feb; 319():129-137. PubMed ID: 31730886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thermolytic Degradation of Synthetic Cannabinoids: Chemical Exposures and Pharmacological Consequences.
    Thomas BF; Lefever TW; Cortes RA; Grabenauer M; Kovach AL; Cox AO; Patel PR; Pollard GT; Marusich JA; Kevin RC; Gamage TF; Wiley JL
    J Pharmacol Exp Ther; 2017 Apr; 361(1):162-171. PubMed ID: 28087785
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Occupational transdermal poisoning with synthetic cannabinoid cumyl-PINACA.
    Dobaja M; Grenc D; Kozelj G; Brvar M
    Clin Toxicol (Phila); 2017 Mar; 55(3):193-195. PubMed ID: 28084855
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of a selection of synthetic cannabinoids and metabolites in urine by UHPSFC-MS/MS and by UHPLC-MS/MS.
    Berg T; Kaur L; Risnes A; Havig SM; Karinen R
    Drug Test Anal; 2016 Jul; 8(7):708-22. PubMed ID: 26304456
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nontargeted SWATH acquisition for identifying 47 synthetic cannabinoid metabolites in human urine by liquid chromatography-high-resolution tandem mass spectrometry.
    Scheidweiler KB; Jarvis MJ; Huestis MA
    Anal Bioanal Chem; 2015 Jan; 407(3):883-97. PubMed ID: 25224637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatotoxicity associated to synthetic cannabinoids use.
    Solimini R; Busardò FP; Rotolo MC; Ricci S; Mastrobattista L; Mortali C; Graziano S; Pellegrini M; di Luca NM; Palmi I
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):1-6. PubMed ID: 28379600
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Repeated Thrombosis After Synthetic Cannabinoid Use.
    Raheemullah A; Laurence TN
    J Emerg Med; 2016 Nov; 51(5):540-543. PubMed ID: 27595371
    [TBL] [Abstract][Full Text] [Related]  

  • 56. First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.
    McQuade D; Hudson S; Dargan PI; Wood DM
    Eur J Clin Pharmacol; 2013 Mar; 69(3):373-6. PubMed ID: 22936123
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of bioisosteric fluorine in synthetic cannabinoid designer drugs JWH-018, AM-2201, UR-144, XLR-11, PB-22, 5F-PB-22, APICA, and STS-135.
    Banister SD; Stuart J; Kevin RC; Edington A; Longworth M; Wilkinson SM; Beinat C; Buchanan AS; Hibbs DE; Glass M; Connor M; McGregor IS; Kassiou M
    ACS Chem Neurosci; 2015 Aug; 6(8):1445-58. PubMed ID: 25921407
    [TBL] [Abstract][Full Text] [Related]  

  • 58. LC-QTOF-MS as a superior strategy to immunoassay for the comprehensive analysis of synthetic cannabinoids in urine.
    Kronstrand R; Brinkhagen L; Birath-Karlsson C; Roman M; Josefsson M
    Anal Bioanal Chem; 2014 Jun; 406(15):3599-609. PubMed ID: 24424965
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Monitoring urinary excretion of cannabinoids by fluorescence-polarization immunoassay: a cannabinoid-to-creatinine ratio study.
    Fraser AD; Worth D
    Ther Drug Monit; 2002 Dec; 24(6):746-50. PubMed ID: 12451292
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quantitative measurement of XLR11 and UR-144 in oral fluid by LC-MS-MS.
    Amaratunga P; Thomas C; Lemberg BL; Lemberg D
    J Anal Toxicol; 2014; 38(6):315-21. PubMed ID: 24812645
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.